Varanasi News Magazine

Blood-Brain Barrier (BBB) Market Size Worth USD 7.40 Billion in 2028, Market Trend – Advancements in healthcare infrastructure

 Breaking News
  • No posts were found

Blood-Brain Barrier (BBB) Market Size Worth USD 7.40 Billion in 2028, Market Trend – Advancements in healthcare infrastructure

April 26
21:33 2021
Major prevalence of neurological disorders and rapidly increasing geriatric population are key factors driving growth of the global blood-brain barrier market

The global blood-brain barrier (BBB) market size is expected to reach USD 7.40 Billion in 2028 at a steady CAGR over the forecast period, according to latest analysis by Emergen Research. Major factors driving market revenue growth include major prevalence of neurological disorders such as Parkinson’s Disease, Alzheimer’s Disease, Hunter’s Syndrome, and brain tumors.

Other factors include rising healthcare expenses and increasing investment in pharmaceutical research and development. Blood-brain barrier plays a vital role in protecting the brain from toxic compounds and many blood-borne disorders. It helps to prevent the circulation of compounds from the circulatory systems to Cerebrospinal Fluid (CSF) or brain through a particular exchange of components controlled by BBB or blood CSF barrier. This function also significantly impedes delivery of drugs to the brain. In case of central nervous system disorders, it is required to deliver drugs across this barrier and provide the appropriate therapeutic effect to the targeted location.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/633

The competitive landscape of the report has been formulated by considering all the vital parameters such as company profiling, market share, recent developments and advancements, gross margins, product portfolio, revenue generation, financial standing, market position, and expansion plans. The report also discusses in detail the recent mergers and acquisitions, joint ventures, collaborations, product launches and brand promotions, agreements, corporate and government deals, and partnerships, among others. The report also sheds light on the recent technological developments and product advancements in the Blood-Brain Barrier (BBB) market.

Key players operating in the market are Allon Therapeutics, Inc., Angiochem Inc., Armagen Technologies, Inc., Bristol-Myers Squibb, BiOasis Technologies, Inc., Sanofi Genzyme, CarThera, Cephalon Inc., Nanomerics, and F. Hoffman La-Roche AG.

For the purpose of this report, Emergen Research has segmented the global blood-brain barrier (BBB) market based on application, technology, end-use, and by region:

  • Application Outlook (Revenue, USD Billion; 2018–2028)
    • Alzheimer’s Disease
    • Epilepsy
    • Parkinson’s Disease
    • Multiple Sclerosis
    • Hunter’s Syndrome
    • Brain Cancer
  • Technology Outlook (Revenue, USD Billion; 2018–2028)
    • Bispecific Antibody RMT Approach
    • Trojan Horse Approach
    • Increasing Permeability
    • Passive Diffusion
    • Others
  • End-Use Outlook (Revenue, USD Billion; 2018–2028)
    • Hospitals
    • Surgical centers
    • Research Institutes
    • Others

The Global Blood-Brain Barrier (BBB) Market is further analyzed across the key geographical locations where the market has expanded to a significant size. The key region analyzed are North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The report offers a country-wise analysis to provide a comprehensive analysis of the Blood-Brain Barrier (BBB) market in terms of production and consumption patterns, supply and demand ratio, import/export, revenue contribution, trends, and presence of prominent players in each region.

To know more about the report, visit @ https://www.emergenresearch.com/industry-report/blood-brain-barrier-market

Regional Analysis Covers:

  • North America (U.S., Canada)
  • Europe (U.K., Italy, Germany, France, Rest of EU)
  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Table of Content

Chapter 1. Methodology & Sources

    1.1. Market Definition

    1.2. Research Scope

    1.3. Methodology

    1.4. Research Sources

          1.4.1. Primary

          1.4.2. Secondary

          1.4.3. Paid Sources

    1.5. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2018-2028

Chapter 3. Key Insights

Chapter 4. Global Blood-Brain Barrier (BBB) Market Segmentation & Impact Analysis

    4.1. Global Blood-Brain Barrier (BBB) Market Segmentation Analysis

    4.2. Industrial Outlook

          4.2.1. Market indicators analysis

          4.2.2. Market drivers analysis

                    4.2.2.1. Growing geriatric population.

                    4.2.2.2. Rising incidences of neurological diseases.

          4.2.3. Market restraints analysis

                    4.2.3.1. Risk of leakage in blood-brain barrier

                    4.2.3.2. High cost of treatment

    4.3. Technological Insights

    4.4. Regulatory Framework

    4.5. Porter’s Five Forces Analysis

    4.6. Competitive Metric Space Analysis

    4.7. Price trend Analysis

    4.8. Covid-19 Impact Analysis

Chapter 5. Global Blood-Brain Barrier (BBB) Market Application Insights & Trends, Revenue (USD Billion)

    5.1. Application Dynamics & Market Share, 2018 & 2028

          5.1.1. Alzheimer’s Disease

          5.1.2. Epilepsy

          5.1.3. Parkinson’s Disease

          5.1.4. Multiple Sclerosis

          5.1.5. Hunter’s Syndrome

          5.1.6. Brain Cancer

Chapter 6. Global Blood-Brain Barrier (BBB) Market Technology Insights & Trends Revenue (USD Billion)

    6.1. Technology Dynamics & Market Share, 2018 & 2028

          6.1.1. Bispecific Antibody RMT Approach

          6.1.2. Trojan Horse Approach

          6.1.3. Increasing Permeability

          6.1.4. Passive Diffusion

          6.1.5. Others

Chapter 7. Global Blood-Brain Barrier (BBB) Market End-Use Insights & Trends Revenue (USD Billion)

    7.1. End-Use Dynamics & Market Share, 2018 & 2028

          7.1.1. Hospitals

          7.1.2. Surgical centers

          7.1.3. Research Institutes

          7.1.4. Others

CONTINUED…!

Check Our Prices: https://www.emergenresearch.com/select-license/633

Thank you for reading our report. Customization of the report is available. To know more, please connect with us, and our team will ensure the report is customized as per your requirements.

Media Contact
Company Name: Emergen Research
Contact Person: Eric Lee
Email: Send Email
Phone: +1 (604) 757-9756
Address:14671 110 Avenue Surrey, British Columbia, V3R2A9
City: Surrey
State: British Columbia
Country: Canada
Website: https://www.emergenresearch.com/industry-report/blood-brain-barrier-market